Ray is a seasoned healthcare business broker and CDMO specialist with over 25 years of experience driving pharmaceutical drug product commercialization. He has successfully led new business development, contract negotiations, and product launches for emerging and specialty pharma companies. With expertise in outsourcing, supply chain strategy, and life cycle management, Ray provides leadership in cross-functional projects, delivering strategic solutions to clinical-stage biotech clients.
Ray Sison
Ben is a healthcare and life science executive with extensive experience bringing pharmaceuticals, vaccines, and medical devices to market. A TEDx speaker and expert in healthcare, pharmaceuticals, and medical devices, he has worked within the world’s leading biotechnology cluster and served on senior management teams driving results across organizations. With deep expertise in quality and regulatory affairs, Ben has collaborated with the FDA and global agencies (MHRA, EMA, PMDA) on Pre-IND, NDA, BLA, clinical trials, and marketed products, as well as PMA and 510(k) devices. He has also trained FDA inspectors and contributed to the Global Quality Metrics Initiative.
Ben Locwin
Kurt has 25 years of experience in generic, brand, biotech, and consumer health pharmaceutical companies, with a strong background in managing businesses, developing and launching new products for global markets, regulatory strategy, sales and marketing of products and technologies, complex international licensing transactions, and M&A. His organizational leadership responsibilities in both B2C and B2B companies span a variety of entrepreneurial and corporate environments (including matrixed global organizations with multiple business units), and he has extensive experience recruiting, building, and retaining talented teams of leaders and managers.
Kurt Nielsen, Ph.D.
Siobhan Ashmore is a global Quality and Regulatory executive with 30 years of experience leading compliance, inspection readiness, and regulatory strategy for pharmaceutical and biotechnology organizations across the U.S., Europe, and Asia-Pacific. She has collaborated extensively with global regulatory agencies throughout her career, including the FDA, MHRA, EMA, and PMDA. She brings deep expertise in pharmaceutical aseptic and sterile operations, which has enabled her to lead the building and development of multiple 503A and 503B compounding pharmacies from initial design through licensing, staff training, and full regulatory certification. Siobhan has accredited facilities on behalf of State Boards of Pharmacy as an Inspector and has guided pharmacies through NABP, VPP, and FDA inspections. Most recently, she has served on executive leadership teams within pharmaceutical organizations, driving operational excellence, risk governance, and global supply chain quality through the integration of advanced technologies, including digital twin systems and emerging AI solutions.
Siobhan Ashmore
